Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock
Background: Current guidelines recommend norepinephrine as the first-line vasopressor in septic shock followed by addition of vasopressin to achieve a goal mean arterial pressure. Limited evidence exists evaluating how the timing of vasopressin addition affects clinical outcomes in septic shock. Obj...
Gespeichert in:
Veröffentlicht in: | The Annals of pharmacotherapy 2023-05, Vol.57 (5), p.521-526 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background:
Current guidelines recommend norepinephrine as the first-line vasopressor in septic shock followed by addition of vasopressin to achieve a goal mean arterial pressure. Limited evidence exists evaluating how the timing of vasopressin addition affects clinical outcomes in septic shock.
Objective:
The objective of this study was to determine whether the timing of the addition of vasopressin to norepinephrine affects shock resolution.
Methods:
This was a multi-site, single system, retrospective cohort, institutional review board (IRB)-approved study examining adult patients with septic shock who received norepinephrine and vasopressin. Patients were divided and statistically analyzed in two subgroups: early vasopressin addition ( |
---|---|
ISSN: | 1060-0280 1542-6270 |
DOI: | 10.1177/10600280221118903 |